{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T04:04:16Z","timestamp":1763697856027,"version":"3.45.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.intimp.2025.115551","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T04:11:02Z","timestamp":1758600662000},"page":"115551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Anti-TNF\u03b1 therapy and microvascular changes: a case-based review of the potential association with early scleroderma pattern development"],"prefix":"10.1016","volume":"166","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0802-6825","authenticated-orcid":false,"given":"Angelo","family":"Nigro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2025.115551_bb0005","first-page":"4","article-title":"Clinical aspects of psoriatic arthritis: one year in review 2024","volume":"43","author":"Esti","year":"2025","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.intimp.2025.115551_bb0010","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1136\/annrheumdis-2020-217159","article-title":"EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update","volume":"79","author":"Gossec","year":"2020","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.intimp.2025.115551_bb0015","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/MD.0b013e3181441a68","article-title":"Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases","volume":"86","author":"Ramos-Casals","year":"2007","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.intimp.2025.115551_bb0020","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s10067-017-3884-2","article-title":"Diverse patterns of anti-TNF-\u03b1-induced lupus: case series and review of the literature","volume":"37","author":"Shovman","year":"2018","journal-title":"Clin. Rheumatol."},{"issue":"9","key":"10.1016\/j.intimp.2025.115551_bb0025","doi-asserted-by":"crossref","first-page":"8187","DOI":"10.3390\/ijms24098187","article-title":"Focus on anti-tumour necrosis factor (TNF)-\u03b1-related autoimmune diseases","volume":"24","author":"Lopetuso","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2025.115551_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2023.101849","article-title":"Nailfold capillaroscopy","volume":"37","author":"Smith","year":"2023","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.intimp.2025.115551_bb0035","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/rheumatology\/kex460","article-title":"EULAR study group on microcirculation in rheumatic diseases et al. reliability of simple capillaroscopic definitions in describing capillary morphology in rheumatic diseases","volume":"57","author":"Cutolo","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.intimp.2025.115551_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.mvr.2020.104036","article-title":"Nailfold capillaroscopy in common non-rheumatic conditions: a systematic review and applications for clinical practice","volume":"131","author":"Ciaffi","year":"2020","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.intimp.2025.115551_bb0045","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1471-2474-13-127","article-title":"Anti-TNF\u03b1 therapy transiently improves high density lipoprotein cholesterol levels and microvascular endothelial function in patients with rheumatoid arthritis: a pilot study","volume":"13","author":"Sandoo","year":"2012","journal-title":"BMC Musculoskelet. Disord."},{"issue":"18","key":"10.1016\/j.intimp.2025.115551_bb0050","doi-asserted-by":"crossref","first-page":"9925","DOI":"10.3390\/ijms25189925","article-title":"Anti TNF-alpha treatment improves microvascular endothelial dysfunction in rheumatoid arthritis patients","volume":"25","author":"Caraba","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.intimp.2025.115551_bb0055","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.3390\/diagnostics13122079","article-title":"Nailfold videocapillaroscopy in patients with rheumatoid arthritis and psoriatic arthropathy on anti-TNF-alpha therapy","volume":"13","author":"Anghel","year":"2023","journal-title":"Diagnostics (Basel)."},{"key":"10.1016\/j.intimp.2025.115551_bb0060","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"12","key":"10.1016\/j.intimp.2025.115551_bb0065","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1093\/rheumatology\/keae197","article-title":"Capi-score: a quantitative algorithm for identifying disease patterns in nailfold videocapillaroscopy","volume":"63","author":"Del Carmelo","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.intimp.2025.115551_bb0070","first-page":"1926","article-title":"The challenge of comprehensive nailfold videocapillaroscopy practice: a further contribution","volume":"40","author":"Gracia Tello","year":"2022","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.intimp.2025.115551_bb0075","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/rheumatology\/kez374","article-title":"Progression of nailfold capillaroscopic patterns and correlation with organ involvement in systemic sclerosis: a 12 year study","volume":"59","author":"Sulli","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.intimp.2025.115551_bb0080","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00296-012-2617-8","article-title":"A patient with ankylosing spondylitis who developed infliximab-induced lupus and treated with etanercept","volume":"34","author":"Akg\u00fcl","year":"2014","journal-title":"Rheumatol. Int."},{"issue":"4","key":"10.1016\/j.intimp.2025.115551_bb0085","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jaad.2020.06.1027","article-title":"Development of morphea in patients receiving biologic therapies: a systematic review","volume":"84","author":"Maliyar","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"issue":"4","key":"10.1016\/j.intimp.2025.115551_bb0090","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3109\/s10165-011-0550-4","article-title":"Morphea associated with the use of adalimumab: a case report and review of the literature","volume":"22","author":"Ram\u00edrez","year":"2012","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.intimp.2025.115551_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102458","article-title":"Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud\u2019s phenomenon and systemic sclerosis","volume":"19","author":"Smith","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.intimp.2025.115551_bb0100","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1093\/rheumatology\/keac630","article-title":"Reading nailfold capillaroscopic images in systemic sclerosis: manual and\/or automated detection?","volume":"62","author":"Cutolo","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.intimp.2025.115551_bb0105","doi-asserted-by":"crossref","first-page":"100","DOI":"10.5152\/eurjrheum.2021.21027","article-title":"How well are biologic and conventional DMARDs tolerated in psoriatic arthritis: a real world study","volume":"9","author":"Jawad","year":"2022","journal-title":"Eur. J. Rheumatol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925015425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925015425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T03:52:46Z","timestamp":1763697166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925015425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":21,"alternative-id":["S1567576925015425"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115551","relation":{},"ISSN":["1567-5769"],"issn-type":[{"type":"print","value":"1567-5769"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-TNF\u03b1 therapy and microvascular changes: a case-based review of the potential association with early scleroderma pattern development","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115551","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115551"}}